Cancer cachexia's metabolic signature in a murine model confirms a distinct entity

Metabolomics

Volumn 9, Issue 3, 2013, Pages 730-739

  Der Torossian, Hirak ^a,b   Asher, Scott A ^c   Winnike, Jason H ^d   Wysong, Ashley ^e   Yin, Xiaoying ^f   Willis, Monte S ^g   O'Connell, Thomas M ^h   Couch, Marion E ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d David H Murdock Research Institute   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h LIPOSCIENCE INC   (United States)

Author keywords

Branched chain amino acids; Cachexia; Caloric restriction; Cancer; Metabolomics; NMR spectroscopy

Indexed keywords

BRANCHED CHAIN AMINO ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CONTROLLED STUDY; FOOD INTAKE; HYPERGLYCEMIA; HYPERLIPIDEMIA; LATENT STRUCTURE ANALYSIS; MALE; METABOLOME; METABOLOMICS; MOUSE; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; WEIGHT REDUCTION;

MURINAE; MUS;

EID: 84877600815     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-012-0485-6     Document Type: Article

References (41)

1. Anthony, J. C., Yoshizawa, F., Anthony, T. G., Vary, T. C., Jefferson, L. S., & Kimball, S. R. (2000). Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. Journal of Nutrition, 130, 2413-2419.
2. Beck, S. A., & Tisdale, M. J. (1989). Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Research, 49, 3800-3804.
3. Bennani-Baiti, N., & Walsh, D. (2009). What is cancer anorexia-cachexia syndrome? A historical perspective. Journal of the Royal College of Physicians of Edinburgh, 39, 257-262.
4. Busquets, S., Alvarez, B., Lopez-Soriano, F. J., & Argiles, J. M. (2002). Branched-chain amino acids: A role in skeletal muscle proteolysis in catabolic states? Journal of Cellular Physiology, 191, 283-289.
5. Busquets, S., Carbo, N., Almendro, V., Figueras, M., Lopez-Soriano, F. J., & Argiles, J. M. (2001). Hyperlipemia: A role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia? FEBS Letters, 505, 255-258.
6. Conti, F., Manganaro, M., & Miccheli, A. (2006). Metabolomics and medical practice. Clinica Terapeutica, 157, 549-552.
7. Darlington, G. J., Wilson, D. R., & Lachman, L. B. (1986). Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. Journal of Cell Biology, 103, 787-793.
8. Delano, M. J., & Moldawer, L. L. (2006). The origins of cachexia in acute and chronic inflammatory diseases. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition, 21, 68-81.
9. Eley, H. L., Russell, S. T., & Tisdale, M. J. (2007). Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. Biochemical Journal, 407, 113-120.
10. Evans, W. J., et al. (2008). Cachexia: A new definition. Clinical Nutrition, 27, 793-799.
11. Fearon, K. C., Glass, D. J., & Guttridge, D. C. (2012). Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell Metabolism, 16, 153-166.
12. Fearon, K. C., & Moses, A. G. (2002). Cancer cachexia. International Journal of Cardiology, 85, 73-81.
13. Fearon, K., et al. (2011). Definition and classification of cancer cachexia: An international consensus. Lancet Oncology, 12, 489-495.
14. Feingold, K. R., Soued, M., Serio, M. K., Moser, A. H., Dinarello, C. A., & Grunfeld, C. (1989). Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology, 125, 267-274.
15. Grunfeld, C., et al. (1989). Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. Cancer Research, 49, 2554-2560.
16. Holecek, M. (2011). Branched-chain amino acid oxidation in skeletal muscle-physiological and clinical importance of its modulation by reactant availability. Current Nutrition & Food Science, 7, 50-56.
17. Holm, E., et al. (1995). Substrate balances across colonic carcinomas in humans. Cancer Research, 55, 1373-1378.
18. Kotler, D. P. (2000). Cachexia. Annals of Internal Medicine, 133, 622-634.
19. Lawton, K. A., et al. (2008). Analysis of the adult human plasma metabolome. Pharmacogenomics, 9, 383-397.
20. Lecker, S. H., et al. (2004). Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB Journal, 18, 39-51.
21. Lee, S. W., Dai, G., Hu, Z., Wang, X., Du, J., & Mitch, W. E. (2004). Regulation of muscle protein degradation: Coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. Journal of the American Society of Nephrology, 15, 1537-1545.
22. Lowenstein, J. M., & Goodman, M. N. (1978). The purine nucleotide cycle in skeletal muscle. Federation Proceedings, 37, 2308-2312.
23. Mahmoud, F. A., & Rivera, N. I. (2002). The role of C-reactive protein as a prognostic indicator in advanced cancer. Current Oncology Reports, 4, 250-255.
24. Mantovani, G., et al. (2010). Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. Journal of Molecular Medicine, 88, 85-92.
25. Martinez-Outschoorn, U. E., et al. (2011). Energy transfer in "parasitic" cancer metabolism: Mitochondria are the powerhouse and Achilles' heel of tumor cells. Cell Cycle, 10, 4208-4216.
26. Nelson, K. A., Walsh, D., & Sheehan, F. A. (1994). The cancer anorexia-cachexia syndrome. Journal of Clinical Oncology, 12, 213-225.
27. Norton, J. A., Gorschboth, C. M., Wesley, R. A., Burt, M. E., & Brennan, M. F. (1985). Fasting plasma amino acid levels in cancer patients. Cancer, 56, 1181-1186.
28. O'Connell, T., et al. (2008). Metabolomic analysis of cancer cachexia reveals distinct lipid and glucose alterations. Metabolomics, 4, 216-225.
29. Perlmutter, D. H., Dinarello, C. A., Punsal, P. I., & Colten, H. R. (1986). Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. Journal of Clinical Investigation, 78, 1349-1354.
30. Pickering, W. P., Price, S. R., Bircher, G., Marinovic, A. C., Mitch, W. E., & Walls, J. (2002). Nutrition in CAPD: Serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney International, 61, 1286-1292.
31. Rieu, I., et al. (2006). Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia. Journal of Physiology, 575, 305-315.
32. Rofe, A. M., Bourgeois, C. S., Coyle, P., Taylor, A., & Abdi, E. A. (1994). Altered insulin response to glucose in weight-losing cancer patients. Anticancer Research, 14, 647-650.
33. Shaw, J. H., & Wolfe, R. R. (1987). Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: The response to glucose infusion, parenteral feeding, and surgical resection. Surgery, 101, 181-191.
34. Strasser, F. (2008). Diagnostic criteria of cachexia and their assessment: Decreased muscle strength and fatigue. Current Opinion in Clinical Nutrition and Metabolic Care, 11, 417-421.
35. Tan, B. H., & Fearon, K. C. (2008). Cachexia: Prevalence and impact in medicine. Current Opinion in Clinical Nutrition and Metabolic Care, 11, 400-407.
36. Tisdale, M. J. (1997). Cancer cachexia: Metabolic alterations and clinical manifestations. Nutrition, 13, 1-7.
37. Tisdale, M. J. (2002). Cachexia in cancer patients. Nature Reviews Cancer, 2, 862-871.
38. van Ravenzwaay, B., et al. (2007). The use of metabolomics for the discovery of new biomarkers of effect. Toxicology Letters, 172, 21-28.
39. Wiklund, S., et al. (2008). Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analytical Chemistry, 80, 115-122.
40. Yoshizawa, F. (2004). Regulation of protein synthesis by branched-chain amino acids in vivo. Biochemical and Biophysical Research Communications, 313, 417-422.
41. Zhou, Q., Du, J., Hu, Z., Walsh, K., & Wang, X. H. (2007). Evidence for adipose-muscle cross talk: Opposing regulation of muscle proteolysis by adiponectin and fatty acids. Endocrinology, 148, 5696-5705.